NSE IPO: Latest Status, Timeline, Valuation and What Investors Should Watch

The National Stock Exchange has been "about to list" for the better part of a decade. What changed in the summer of 2026 is that the paperwork finally exists: a draft prospectus dated 17 June 2026, the legacy regulatory matters settled, and a Supreme Court that has now disposed of the appeals which stood in the way. What has not changed is that there is still no price, no red herring prospectus and no confirmed date.

That gap between "filed" and "launched" is where most of the confusion sits, so this article separates the two. Everything in the first half comes from the DRHP itself or SEBI's filing register. Everything reported rather than filed is labelled as such.

What the DRHP actually says

The offer is up to 148,905,525 equity shares of ₹1 face value. Against a pre-offer capital of 2,475,000,000 shares, that is roughly 6% of the company.

The structure matters more than the size. This is a pure offer for sale — the DRHP records the fresh issue size as "not applicable". Every rupee paid by investors goes to the shareholders who are selling. NSE itself receives nothing, and no proceeds fund any expansion, technology spend or acquisition. If you are used to reading an IPO's objects of the issue to understand what the company will do with the money, there is nothing to read here: the stated objects are to carry out the offer for sale and to achieve the benefits of listing.

The listing venue is unusual and worth stating plainly: NSE will list on BSE. The SECC Regulations do not permit an exchange to list on itself, and the DRHP says so in its own risk factors. BSE is the designated stock exchange for the offer.

Who is selling, and who is not

Twenty-three shareholders are selling — nineteen corporate and four individual. The largest are State Bank of India (up to 24,750,000 shares), MS Strategic (Mauritius), Canada Pension Plan Investment Board, Aranda Investments (Mauritius) and Bank of Baroda.

The DRHP also discloses what those sellers paid, and the numbers are striking. State Bank of India's weighted average cost of acquisition is ₹0.80 per share. Bank of Baroda's is ₹0.54, Stock Holding Corporation's ₹0.46, and The New India Assurance's ₹0.32. These are holdings from the exchange's earliest days, and the offer is the first practical route to liquidity for them.

One absence is as informative as the sales. LIC is NSE's largest shareholder at 10.72% and appears nowhere in the list of selling shareholders. Business Standard has reported that it is retaining its entire holding.

Why it took a decade

The obstacle was never appetite. It was the co-location matter — the long-running question of preferential access to NSE's trading systems — together with a related dark-fibre issue. Those proceedings made a listing impractical while they were live.

Both were resolved through the settlement route. The amount was ₹1,491.21 crore, with SEBI's in-principle acceptance conveyed by email dated 30 July 2026, of which ₹714.74 crore was paid in cash. On 3 September 2026 the Supreme Court disposed of SEBI's appeals, and multiple outlets then reported that SEBI issued its observation letter on 4 September 2026.

An observation letter is not the finish line. It permits the company to file a red herring prospectus. Price band, lot size and dates all arrive with that document, and none of them exist yet.

The business, and the concentration inside it

NSE earns from transaction charges on trades, listing fees from companies, data and index licensing, and clearing. That sounds diversified. It is not.

Transaction charges are 78.65% of operating revenue, and options alone account for 60.22%. Nearly two thirds of what this exchange earns depends on one product category, and that category is the most heavily regulated part of the Indian market. Anyone underwriting this business is, whether they frame it that way or not, taking a view on future regulation of index derivatives.

FY26 went the wrong way

This is the part of the story that headline coverage tends to skip. Revenue from operations fell to ₹1,66,013.09 million — about ₹16,601 crore — from ₹1,71,406.78 million in FY25. Profit for the year fell to ₹1,03,020.61 million, about ₹10,302 crore, from ₹1,21,876.89 million.

Both lines went down. Very few large Indian IPOs come to market on a year of falling revenue and falling profit, and the reason here is the same concentration described above: measures affecting derivatives volumes feed almost directly into the top line. August 2026 futures and options turnover reportedly hit a fourteen-month low after the closing auction session was introduced.

None of this makes the business weak. It makes the business cyclical in a way that is driven by rule changes rather than by the economy, which is a different thing to underwrite. When you read an IPO's financials, a single year's direction matters less than understanding what drives it — and here what drives it is policy.

NSE and BSE, as investable propositions

BSE is already listed, which makes it the nearest reference point for anyone trying to value NSE — and it is an imperfect one. The two exchanges are not the same business in different sizes. NSE dominates cash equity and, overwhelmingly, derivatives; BSE's revenue mix and market share are different in both.

If you want the structural comparison first, we have written it separately: NSE vs BSE covers what each exchange is, how they differ and why one came to dominate derivatives. Read that before trying to map BSE's multiple onto NSE.

Unlisted shares are not a preview of the IPO price

NSE shares change hands off-market through dealers, and those quotes get reported as though they were prices. They are not comparable to what the IPO will cost.

An unlisted trade is a negotiated transaction with no exchange, no order book, no continuous quote and no regulated price discovery. Liquidity is thin, the spread is wide, and the price reflects whoever was willing to deal that week. The IPO price band will be set by book building against institutional demand, and it can land materially above or below the unlisted market in either direction. The same caution applies to any grey market premium quoted for an issue that has no price band — a premium needs an issue price to be a premium over.

What to watch, in order

• The red herring prospectus. Until it is filed, there is no price band, no lot size and no dates — and no basis for any of them.
• The final offer size in rupees, which only exists once the price band does.
• Any further regulatory development on index derivatives, since that is where roughly 60% of operating revenue comes from.
• Quarterly turnover trends, which are the closest thing to a live read on the revenue line.
• Whether the FY26 decline continues into FY27 or proves to be a one-year effect of specific rule changes.

Where to follow it

We maintain a page for this issue that updates as the filings do: the NSE IPO detail page carries the dates, structure and status as they are confirmed, rather than as they are expected. The IPO Center lists everything currently open, and upcoming IPOs shows what is queued behind it.

If any part of the process itself is unfamiliar, start with what an IPO is and how to apply for one.

The honest summary

NSE is a genuinely dominant piece of Indian market infrastructure that is finally, after a decade, close to listing. It is also a pure exit for existing shareholders, in a company whose revenue and profit both fell last year, with roughly 60% of operating revenue riding on one regulated product category, and with no price band yet to judge any of it against.

Both halves of that are true at once. Anyone telling you the answer before the price band exists is telling you something they cannot know.

This article is educational and is not investment advice. Figures are from the offer document and company disclosures as at the dates given; verify against the final prospectus before applying.